Showing 481-490 of 817 results for "".
Mind Your Mannerisms
https://practicaldermatology.com/topics/practice-management/mind-your-mannerisms/20540/Body language can have a lot to do with establishing rapport and trust and supporting long-term adherence.Assessing the Need for Re-Excision in Mild to Moderate Dysplastic Nevi
https://practicaldermatology.com/topics/skin-cancer-photoprotection/assessing-the-need-for-re-excision-in-mild-to-moderate-dysplastic-nevi/21247/Re-excision may not be clinically warranted in a majority of cases.Lichen Amyloidosis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/lichen-amyloidosis/20681/Case Report: Flagellate Dermatitis
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-flagellate-dermatitis/21206/Can Google Help with Difficult-to-Determine Etiology?Type Casting: Assessing Personality Before a Hire
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/type-casting-assessing-personality-before-a-hire/22994/Can the Myers–Briggs Type Indicator take the guess work out of your next hiring decision?Don't Shoot the Messenger
https://practicaldermatology.com/topics/practice-management/dont-shoot-the-messenger/20791/Act now to avoid a seven percent MIPS penalty in 2021.CSF After Dark
https://practicaldermatology.com/topics/practice-management/csf-after-dark/20404/What happens in Vegas stays in Vegas. Or does it?Take 5
https://practicaldermatology.com/columns/take-5/take-5/21798/Take 5: Clinically-Relevant Findings About Causes and Treatment of Rosacea
https://practicaldermatology.com/columns/take-5/take-5-clinically-relevant-findings-about-causes-and-treatment-of-rosacea/21870/Research sheds light on the pathogenesis of the disease and patients' experience.Take 5: Recent Developments in Systemic Therapy for Psoriasis
https://practicaldermatology.com/columns/recent-developments/take-5-recent-developments-in-systemic-therapy-for-psoriasis/22002/New data reveal noteworthy financial and clinical trends in the use of systemic agents.